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Edited by Frances ShannonAbstract Death domain-associated protein (Daxx) regulates
both transcription and apoptosis. The role of Daxx in transcrip-
tion is not well understood. Here, we show that Daxx interacts
with Skip/NcoA62, a transcription cofactor that modulates the
activity of oncoproteins including Ski and NotchIC. Daxx
strongly binds with Skip both in vitro and in mammalian cells.
This interaction is mediated by the PAH2 domain of Daxx
and the highly conserved SNW domain of Skip. Daxx partially
co-localizes with Skip in vivo and changes the cellular distribu-
tion of Skip. In addition, Skip represses transcription when teth-
ered to a promoter, and Daxx antagonizes this activity.
Furthermore, Skip is phosphorylated at serine 224 in its SNW
domain. These results suggest a novel function of Daxx in tran-
scription regulation through alteration of the cellular localization
of Skip.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The death domain-associated protein (Daxx) regulates apop-
tosis as well as transcription. It was ﬁrst discovered as an adap-
ter protein that interacts with the intracellular region of the
CD95 (Fas/Apo-1) death receptor and participates in CD95-
mediated apoptosis through the activation of Jun NH2-termi-
nal kinase (JNK) [1]. Daxx interacts with a JNK kinase kinase,
the apoptosis signal-regulating kinase 1 (ASK1), relieving an
inhibitory intramolecular interaction between its NH2- and
COOH-terminal regions [2,3]. Daxx also associates with the
cytoplasmic domain of the transforming growth factor-b
(TGF-b) receptor, linking this receptor to the JNK pathway
and contributing to apoptosis [4]. Daxx can be found in both
the nucleus and the cytosol. However, in most cell types, Daxx
is predominantly localized in the nucleus. Translocation of
Daxx to the cytosol occurs upon CD95 engagement, which is
enhanced by ASK1 and inhibited by the heat shock protein
27 [5–7]. In contrast, Daxx is present in the cytosol in primary
splenocytes and translocates to the nucleus upon mitogenic
activation, where it participates in apoptosis induction [8].
Similarly, Daxx moves from the cytosol to the nucleus during
interferon-induced cell death of progenitor B cells in a Tyk2 (a*Corresponding author.
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ner, which promotes apoptosis [9,10].
Nuclear Daxx primarily resides in the promyelocytic leuke-
mia protein nuclear bodies (PML-NBs), subnuclear structures
whose disruption is implicated in the pathogeneses of promye-
locytic leukemia. PML-NBs may regulate a range of important
cellular processes such as anti-viral responses, cellular senes-
cence, and apoptosis [11–13]. The interaction of Daxx with
the PML-NBs is mediated by PML [8,14,15], and the apoptotic
function of nuclear Daxx is likely related to its PML-NB local-
ization [8,16]. Accumulating evidence suggests that nuclear
Daxx plays a role in transcriptional regulation. When tethered
to DNA, as both the NH2- and the COOH-terminal regions of
Daxx are able to do, Daxx strongly represses transcription
[15]. The Daxx COOH-terminal region interacts with se-
quence-speciﬁc transcription factors Pax3, Pax5, ETS-1, and
the glucocorticoid receptor, and it either inhibits or enhances
transcription in a cell- and promoter-speciﬁc manner [17–20].
The NH2-terminal region has recently been shown to associate
with ATRX, a chromatin-remodeling molecule whose muta-
tions are associated with X-linked mental retardation and a-
thalassemia syndrome (ATR-X syndrome). Daxx and ATRX
form a novel chromatin-remodeling complex, with ATRX
being the core ATPase and Daxx being the targeting subunit
[21,22]. Despite identiﬁcation of these Daxx interactors, the
role of Daxx in transcription remains unclear.
We hypothesized that additional eﬀector proteins may inter-
act with the NH2-terminal region of Daxx, allowing Daxx to
target other general transcriptional regulators to sequence-
speciﬁc DNA binding proteins and their associated promoters.
We performed a yeast two-hybrid screen and identiﬁed Ski
interacting protein (Skip, also known as NcoA-62) as having
a strong interaction with Daxx. Skip is a nuclear protein highly
conserved in diverse species, including animals, yeast, and
plants [23–26], and it is essential for the survival of these
organisms [23–26]. Several lines of evidence indicate that Skip
is a critical transcription co-factor. First, Skip associates with
the oncoprotein Ski, the cellular counterpart of v-Ski and a
critical component of a histone deacetylase complex required
for transcription repression by the thyroid hormone receptor
[23,27]. Second, Skip enhances gene expression mediated by
the vitamin D receptor and other transcription factors
[24,28–30]. In addition, Skip is involved in the activation of
the CBF1-repressed gene by EBNA2 (the Epstein-Barr virus
encoded latency protein) and the active form of the transmem-
brane receptor Notch (NotchIC) [31,32]. In the case ofblished by Elsevier B.V. All rights reserved.
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resting cells and facilitates targeting of the SMRT/HDAC
co-repressor complex to CBF1. Upon stimulation of the Notch
pathway, Skip promotes tethering of the transcription activa-
tor NotchIC to CBF-1 [32]. Thus, Skip serves as a docking site
for both transcription co-activators and co-repressors. Fur-
thermore, the Drosophila Skip homolog, Bx42, is associated
with chromatin in transcriptionally active puﬀs of salivary
glands and is involved in ecdysone-stimulated gene expression
[25]. A recent study showed that knocking-down of Skip in
Caenorhabditis elegans results in embryonic arrest similar to
that caused by the inhibition of RNA polymerase II [33], sug-
gesting that Skip may be an essential component of various
RNA polymerase II transcription complexes. However, the
mechanism that regulates Skip function is not well understood.
In this study, we show that Daxx and Skip associate with
each other in mammalian cells. This interaction is mediated
by the PAH2 domain of Daxx and the highly conserved
SNW domain of Skip. We show that Daxx modulates Skip
localization and its transcription activity. In addition, we dem-
onstrate that Skip is phosphorylated on a serine residue within
the SNW domain. These results suggest that Daxx regulates
Skips function through alteration of its cellular localization
and reveals a novel function of nuclear Daxx in transcription
regulation.2. Materials and methods
2.1. Yeast two-hybrid screen
The NH2-terminal region of murine Daxx (containing amino acids
1–501) was fused to the Gal4 DNA binding domain (Gal-DBD) in
the yeast expression plasmid pASII [34]. The resulting plasmid, Gal-
DaxxN was co-transformed with a library of fusions between the
Gal4 activation domain and cDNAs from murine T cells (CLON-
TECH) into a reporter yeast strain, Y190, which harbored the lacZ
and his3 genes under the control of a Gal promoter. Transformants
were grown on plates selective for both plasmids and His prototrophy.
Positive clones were isolated and further tested for the strength of
interaction by ﬁlter lift assay of b-galactosidase activity [35]. The li-
brary plasmids from the strong interacting clones were isolated and
re-transformed back into the reporter strain to test for interaction with
Daxx as well as with various un-related control baits. The cDNA in-
serts in the library plasmids that encode proteins speciﬁcally interact-
ing with Daxx were subsequently analyzed by sequencing.
2.2. Plasmids
Human Skip was cloned from a lymph node cDNA library (CLON-
TECH) by PCR using a forward primer 5 0 CGCGGATC-
CATGGCGCTCACCAGCTT with a BamHI site (in bold) and a
reverse primer 5 0 CGCGTCGACTTCCTTCCTCCTCTT with a SalI
site (in bold). The PCR product was subcloned into pRK5 with either
an NH2-terminal HA or FLAG tag. All Skip deletion and fragments,
as well as Daxx (260–740) and Daxx (157–260), were generated by
PCR and cloned into pRK5 with an NH2-terminal FLAG tag. Skip
and its deletion fragments were also COOH-terminally fused to green
ﬂuorescence protein (GFP) in pEGFP-C1 (CLONTECH) and to the
Gal4 DNA-binding domain in pRK5. Point mutations within the
SNW domain were generated by overlap PCR. All plasmids were con-
ﬁrmed by sequencing. The other Daxx expression plasmids used in this
study were previously described [21].
2.3. Immunoﬂuorescence
Immunoﬂuorescence analysis was performed essentially as previ-
ously described [21,36]. Brieﬂy, MCF7, U2OS, and 293T cells seeded
on coverslips in 24-well plates were transfected on the second day with
plasmids encoding Skip-GFP and HA/FLAG-Daxx using Superfect
(Qiagen) or lipofectamine 2000 (Invitrogen) following the manufac-turers instructions and the calcium phosphate precipitation method,
respectively. Twenty-four hours later, the cells were washed twice with
cold PBS, ﬁxed with 2% paraformaldehyde and permeablized in 0.2%
Triton in PBS at 4 C for 10 min. For immunostaining, MCF7 and
U2OS cells were incubated with an anti-Daxx (M-112, Santa Cruz Bio-
technology), followed by a Texas-red conjugated secondary antibody.
Cells were dehydrated with ethanol, and mounted with Vectashield
mounting medium (Vector laboratories). Images were recorded by a
BioRad 1024-ES confocal laser-scanning microscope or an epi-ﬂuores-
cence microscope.
2.4. Immunoprecipitation, SDS–PAGE and Western blotting
293T cells grown in 60 mm plates were transfected with the indicated
plasmids (5 lg each). Twenty-four hours later, the cells were washed
with cold PBS twice and lysed in 500 ll of lysis buﬀer (20 mM Tris–
HCl, pH 7.4, 150 mM NaCl, 1 mM DTT, 1 mM EDTA, 10% glycerol,
1 mM PMSF and aprotinin) for 15 min on ice. Cell lysates were immu-
noprecipitated with anti-FLAG M2 beads. After being extensively
washed, the precipitated immuno-complex was resolved by SDS–
PAGE and analyzed by immunoblotting with the indicated antibodies
and ECL reagents. To generate recombinant FLAG-Daxx, FLAG-
Daxx was transiently overexpressed in 293T cells and puriﬁed on M2
beads. The non-speciﬁc proteins were removed though sequential
washes with lysis buﬀers containing 150 mM KCl, 0.5 M KCl and
1 M KCl. The same procedure was performed to the control, in which
FLAG/pRK5 was used for transfection. HA-Skip was in vitro trans-
lated and labeled with 35S-methionine using a coupled in vitro tran-
scription/translation system (Promega). 35S-Skip was incubated with
immobilized FLAG-Daxx in lysis buﬀer at 4 C for 2 h of incubation.
After extensive wishing, the bound proteins were analyzed by SDS–
PAGE and autoradiography.
2.5. In vivo labeling of Skip with 32Pi
Potential phosphorylation sites on Skip were analyzed using the Net-
Phos program (www.cbs.dtu.dk/services/NetPhos) [37]. In vivo labeling
was performedasdescribedwithmodiﬁcations [38]. 293Tcells grown in a
6-well plate were transfected with FLAG-Skip, FLAG-SkipM and their
correspondingSer224-to-Alamutants. Twenty-four hours later, the cells
were washed once with phosphate-freeDMEMcontaining 10%dialyzed
fetal calf serum. The cells were pre-incubated in the samemedium for 2 h
before adding 32Pi (200 lCi/ml; Amersham Pharmacia Biotech). After
two hours of labeling at 37 C, the cells were washedwith cold PBS twice
and lysed in lysis buﬀer. FLAG-tagged proteins were immunoprecipi-
tated with M2 beads, and the labeled proteins were analyzed by SDS–
PAGE followed by autoradiography.
2.6. Reporter assay
293T cells grown in 24-well plates were transfected with the indi-
cated plasmids, together with 0.5 lg of 5Xgal-TK-luciferase reporter
gene plasmid [39] and 50 ng of pCMV-b-galactosidase. Empty vector
pRK5 was added to keep the total amount of DNA transfected con-
stant. Twenty-four hours later, the cells were lysed, and the luciferase
activity was measured using a ﬁreﬂy luciferase system (Promega),
according to the manufacturers instructions. The activity of b-galacto-
sidase co-transfected was also measured to normalize luciferase activ-
ity. The expression levels of Gal-DBD and Gal-Skip in whole cell
lysates were examined by Western blotting with an anti-Gal-DBD anti-
body (Santa Cruz).3. Results
3.1. Interaction of Daxx and Skip
To better understand the function of Daxx and in particular,
its NH2-terminal region, we performed a yeast two-hybrid
screen using the murine Daxx NH2-terminal region (amino
acids 1–501) as bait. A fusion of this region with Gal4
DNA-binding domain was transformed into a reporter yeast
strain together with a library of fusions of the Gal4 transcrip-
tion activation domain and cDNA from murine T cells. The
positive clones were selected based on both the expression of
Fig. 1. Association of Daxx and Skip in mammalian cells and in vitro.
(A) and (B) Daxx interacts with Skip in mammalian cells. (A) HA-
tagged Daxx was either expressed alone or together with FLAG-tagged
Skip (F-Skip) in 293T cells. Cell lysates were immunoprecipitated with
anti-FLAG mAb M2 immobilized on agarose beads, and the immu-
noprecipitates were resolved on SDS–PAGE and analyzed by Western
blotting using either an anti-HA antibody to detect HA-Daxx (top
panel) or an anti-FLAG antibody to detect FLAG-Skip (middle). The
expression of HA-Daxx in the lysates is shown at the bottom. (B)
FLAG-Daxx and HA-Skip were co-expressed in 293T cells and their
interaction was examined by anti-FLAG immunoprecipitation as in
(A). (C) Puriﬁed recombinant Daxx binds to Skip in vitro. Left:
FLAG-Daxx was transiently expressed in 293T cells and aﬃnity
puriﬁed to homogeneity on M2 beads. The recombinant FLAG-Daxx
bound to M2 beads and a control sample (C) from vector-transfected
cells were analyzed by SDS–PAGE and Coomassie Blue Staining. The
asterisks indicate antibody heavy and light chains. MW, molecular
weight standards (in kDa). Right: In vitro translated, 35S-methionine-
labeled HA-Skip was incubated with either FLAG-Daxx or the control
M2 beads. After extensive washing, the bound proteins were analyzed
by SDS–PAGE and autoradiography.
Fig. 2. The PAH2 region of Daxx mediates its interaction with Skip.
(A) Schematic presentation of full length Daxx and its deletion
mutants. PAH, paired amphipathic alpha helices domain; AD, acid-
rich region; SPT, Ser/Pro/Thr-rich domain. The amino acids present in
each fragment are indicated on the left and their interactions with Skip
are summarized on the right. (B) The PAH2 region of Daxx binds to
Skip. FLAG-tagged Daxx constructs were co-transfected with HA-
Skip into 293T cells. Cell lysates were immunoprecipitated with the
anti-FLAG antibody M2. The presence of HA-Skip and FLAG-Daxx
in the precipitates and/or lysates was detected by immunoblotting with
an anti-HA antibody and M2. Molecular weight standards (in kDa)
are shown on the left.
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nies a blue color in the presence of a chromogenic substrate
X-gal, and that of the his3 gene, which allowed the colonies
to grow on histidine-deﬁcient plates. Several positive clones
were identiﬁed among approximately 5 · 105 library plasmids
screened. A strong Daxx interactor, Skip, was selected for fur-
ther study.
To determine whether Daxx could interact with Skip in
mammalian cells, we transfected human embryonic kidney
293T cells with a plasmid expressing human Daxx (HA-
tagged) alone or together with a plasmid expressing human
Skip (FLAG-tagged). The transfected cell lysates were immu-noprecipitated with an anti-FLAG antibody M2 and the
immunoprecipitated Daxx was detected by immunoblotting
analysis. This co-immunoprecipitation assay revealed that
Daxx strongly interacted with Skip (Fig. 1A). Reciprocally,
we co-transfected FLAG-Daxx and HA-Skip into 293T cells.
Skip was found to be present in the anti-FLAG immunopre-
cipitates, conﬁrming the interaction between Daxx and Skip
(Fig. 1B).
To examine whether Daxx and Skip can directly associate
with each other, we expressed recombinant FLAG-Daxx in
293T cells and aﬃnity puriﬁed it to homogeneity using M2
beads (Fig. 1C, lane 3). In vitro translated 35S-Skip bound to
puriﬁed recombinant FLAG-Daxx immobilized on the M2
beads but no to the control beads (Fig. 1C, right panel), sug-
gesting that Daxx can directly interact with Skip.
3.2. Skip interacts with Daxx through its SNW domain
Because Skip was identiﬁed using the NH2-terminus of Daxx
as bait for the two-hybrid screen, we wished to conﬁrm that
this region mediated the interaction of Daxx with Skip in
mammalian cells. A panel of Daxx deletion mutants were
tested for the interactions with Skip using co-immunoprecipi-
tation assays. As shown in Fig. 2, the region containing the
Fig. 3. Skip interacts with Daxx through its SNW domain. (A)
Diagram of full length Skip and its deletion mutants. The SNW
domain of Skip contains a Ser-Asn-Trp sequence and is conserved
across diﬀerent species. The amino acids present in each fragment are
indicated on the left. (B) Interaction of various Skip fragments with
Daxx. Interactions of HA-Daxx with diﬀerent Skip fragments tagged
with FLAG were examined as in Fig. 2B. The slower migration of
SkipM compared to SkipN and C might be due to its relative high
content of basic residues.
Fig. 4. Co-localization of Daxx and Skip in transfected cells. (A) Co-localizat
co-expressed in MCF7 cells. Localization of transfected Daxx (examined usin
antibody) and of Skip-GFP and the merged image are shown. (B) Daxx modu
cells in the absence (a) or presence (b–d) of HA-Daxx. The localization of
modulates the cellular localization of Skip and the Skip fragments with whic
were expressed in the absence (panels a–e) or presence (f–j) of FLAG-Daxx
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no acids 157–260) was mainly responsible for the interaction
with Skip. Skip is thus one of the few proteins that have been
shown to associate with the NH2-terminal region of Daxx. An-
other protein that associates with this region is ATRX, which
binds to the PAH1 domain [21].
To determine the region of Skip that mediates its interaction
with Daxx, we made a series of Skip deletion mutants, each
tagged with a FLAG epitope (Fig. 3A). Skip is comprised of
a central SNW domain, which is characterized by the presence
of a Ser-Asn-Trp sequence and is highly conserved across spe-
cies. Co-immunoprecipitation assays revealed that the SkipDC
and SkipM fragments, both containing the SNW domain,
interacted strongly with Daxx (Fig. 3B, lanes 2 and 5). The
NH2-terminal region (amino acids 1–180) interacted weakly,
and the COOH-terminal region (amino acids 350–536) did
not interact at all (lanes 3 and 4). These results indicate that
the evolutionarily conserved SNW domain of Skip is the main
region that mediates its interaction with Daxx.3.3. Co-localization of Daxx and Skip in mammalian cells
To conﬁrm the interaction between Daxx and Skip, we
examined whether these two proteins co-localized with each
other when expressed in mammalian cells. Daxx shows a dif-
fuse and/or speckled nuclear pattern when expressed alone,
depending on the cell type and Daxx expression level, likely be-ion of Daxx and Skip in MCF7 cells. FLAG-Daxx and Skip-GFP were
g an anti-Daxx antibody followed by Texas red-conjugated secondary
lates the cellular localization of Skip. Skip-GFP was expressed in U2OS
Skip-GFP and HA-Daxx and merged images are shown. (C) Daxx
h it interacts. GFP fusions of full-length Skip and its deletion mutants
in 293T cells. The localization of Skip-GFP proteins is shown.
Fig. 5. Phosphorylation of Skip at serine 224. (A) Possible phosphor-
ylation sites (underlined) and their ﬂanking sequences within the Skip
SNW domain. (B) Serine 224 as a potential phosphorylation site.
FLAG-tagged wild type Skip SNW domain and various Ser/Thr-to-
Ala mutants were expressed in 293T cells, immunoprecipitated by anti-
FLAG antibody, and analyzed by SDS–PAGE followed by Coomassie
blue staining. (C) Phosphorylation of Skip in mammalian cells. FLAG-
tagged full length Skip and its SNW domain, and their corresponding
Ser224-to-Ala mutants were expressed in 293T cells. The cells were
labeled with 32P, and the Skip proteins were immunoprecipitated by
anti-FLAG antibody. The precipitates were resolved by SDS–PAGE
and analyzed by autoradiography (left) and immunoblotting (right).
(D) Mutations of Ser224 of Skip do not aﬀect its interaction with
Daxx. HA-Daxx was co-transfected with vector, F-Skip, F-
Skip(S224E), or F-Skip(S224A) into 293T as indicated. Cell lysates
were immunoprecipitated with the anti-FLAG antibody M2. The
immunoprecipitates and lysates were analyzed by Western blotting
with the indicated antibodies.
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PML [8,14,15]. To ensure Skip and Daxx co-localize in both
scenarios, we examined their co-localization in three diﬀerent
cell lines. Daxx shows speckles in MCF7 cells and is nuclear
diﬀused in U2OS and 293T cells. We ﬁrst expressed green ﬂuo-
rescence protein (GFP)-tagged Skip with Daxx in human
mammary carcinoma MCF7 cells. Daxx was detected by
immunostaining using an anti-Daxx antibody and a Texas-
red conjugated secondary body. As indicated in Fig. 4A, Daxx
showed a diﬀuse staining pattern with prominent nuclear
speckles (panel a). Notably, GFP-Skip was partially co-local-
ized with the Daxx speckles (panels b and c). We next exam-
ined the Daxx:Skip co-localization in human osterocarcoma
U2OS cells. Overexpressed Skip alone showed a nuclear speck-
led distribution in these cells (Fig. 4B, panel a), while the local-
ization pattern of Daxx was nuclear diﬀuse (panel c). However,
when co-expressed with Daxx, the localization pattern of Skip
was changed to nuclear diﬀuse (panels b and d), suggesting that
Daxx and Skip co-localize in the cells and Daxx could alter the
cellular localization of Skip. In addition, we transfected GFP-
Skip alone or together with Daxx into 293T cells. When ex-
pressed alone, full length Skip was mainly localized in nuclear
speckles, as in U2OS cells (Fig. 4C, panel a), while Daxx
showed diﬀuse nuclear localization (data not shown). Interest-
ingly, when co-expressed with Daxx, Skip became diﬀusely nu-
clear and partially co-localized with Daxx (panel f).
Furthermore, we examined the eﬀect of Daxx on the localiza-
tion of various Skip deletion mutants tagged with GFP. Both
GFP-SkipDC and -SkipM, which lacked the COOH-terminal
region, were found in the cytosol when expressed alone (panels
b and e), whereas GFP-SkipC was exclusively nuclear (panel
c), indicating that the COOH-terminal region of Skip contains
the nuclear localization signal. Interestingly, in the presence of
Daxx, a large portion of GFP-SkipDC and -SkipM translo-
cated to the nucleus (panels g and j), consistent with the ability
of these two mutants to interact with Daxx (Fig. 2). In con-
trast, the localization of SkipN, which interacted weakly with
Daxx, was not aﬀected by co-transfection with Daxx (panels d
and i). Taken together, these results show that Daxx and Skip
interact in mammalian cells and suggest that Daxx may alter
the cellular localization of Skip.
3.4. Skip is phosphorylated at serine 224
When we tested the Daxx:Skip interaction, we noticed that
SkipM migrated on SDS–PAGE as double bands with slightly
diﬀerent molecular weights, suggesting that this fragment of
Skip might be phosphorylated (Fig. 5B). To explore this possi-
bility, we analyzed its sequence and identiﬁed four possible
phosphorylation sites within the SNW domain (Fig. 5A). We
mutated each of these sites to Ala. These point mutants, each
tagged with a FLAG epitope, were overexpressed in 293T cells,
immunoprecipitated with anti-FLAG antibody, and examined
by SDS–PAGE and Coomassie blue protein staining. Of the
four mutants, only the Ser224-to-Ala mutant migrated as a sin-
gle band, indicating Ser224 as a potential phosphorylation site.
To conﬁrm that both SkipM and full-length Skip are phos-
phorylated, we expressed these proteins and their correspond-
ing Ser224Ala mutant proteins (each with a FLAG tag) in
293T cells and labeled the cells with 32Pi. Anti-FLAG immu-
noprecipitates were analyzed by SDS–PAGE and autoradiog-
raphy. Notably, both full-length Skip and its COOH-terminal
fragments, but not their corresponding Ser224Ala mutants,were labeled by 32P (Fig. 5C, lanes 2 and 4 vs. 3 and 5). Immu-
noblotting analysis conﬁrmed comparable expression levels of
the wild type and mutant Skip proteins (lane 7 vs. 8 and lane 9
vs. 10). Thus, Skip is likely to be phosphorylated on Ser224 in
the highly conserved SNW domain. Skip Ser224Ala mutant
showed similar pattern of cellular localization to that of wild
type protein (data not shown). In addition, the mutant inter-
Fig. 6. Daxx alleviates the transcription repression activity of Skip. (A) Transcription repression mediated by Skip. 293T cells were transfected with
the indicated amount of GAL4 DNA-binding domain (Gal-DBD), a Gal-DBD fusion of Skip (Gal-Skip), or a vector control (), together with a
5xGal-TK-luciferase reporter and pCMV-lacZ plasmid. The total amounts of DNA were made constant by adding vector DNA. The luciferase
activities were normalized with b-galactosidase expression and were relative to that of the extracts from vector-transfected cells. The data are
representative of four independent experiments. The expression levels of GAL-BDB and GAL-Skip are shown in the insert. (B) The SNW domain of
Skip possesses transcription repression activity. 293T cells were transfected with 250 ng of either Gal-DBD or Gal-DBD fusions of various Skip
fragments, plus the luciferase reporter and pCMV-LacZ plasmids. Normalized luciferase activities are shown relative to Gal-DBD. (C) Daxx inhibits
the transcription repression activity of Skip. 293T cells were transfected with either Gal-DBD or Gal-DBD fusions of the indicated Skip fragments
(100 ng), together with diﬀerent amounts of Daxx. The relative luciferase activities were calculated as in (B).
2888 J. Tang et al. / FEBS Letters 579 (2005) 2883–2890acted as well as wild type with Daxx (Fig. 5D). Therefore, the
phosphorylation state of Skip does not appear to aﬀect its
localization or the Skip:Daxx interaction.
3.5. Daxx inhibits the SNW domain-mediated transcriptional
repression activity of Skip
Given that Skip is a transcription regulatory protein
whose cellular localization is modulated by Daxx, we exam-ined whether Daxx could aﬀect the transcription activity of
Skip. Skip was fused to the Gal4 DNA binding-domain
(Gal-DBD), and the resulting Gal4-Skip fusion was intro-
duced into 293T cells together with a luciferase reporter gene
driven by a thymidine kinase (TK) promoter that contained
ﬁve Gal4-binding sites. Skip repressed the transcription of
the luciferase reporter gene up to 80% in a dose-dependent
manner (Fig. 6A, lanes 4–8). This result is consistent with
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bound transcription factors [32]. Analysis of various Skip
mutants revealed that this repression activity resides mainly
in the conserved SNW domain, because both SkipDC and
SkipM, which contained the SNW domain, showed strong
repression activity (Fig. 6B, lanes 3 and 6), while SkipC
and SkipN, which lacked the SNW domain, showed weak
or no repression activity (lanes 4 and 5). When Daxx was
introduced into this assay, it relieved the transcription
repression activity of the full length Skip (Fig. 6C, column
2). Consistent with its strong interaction with the SNW do-
main, Daxx also signiﬁcantly inhibited the transcription
repression of Skip mutants that contained this domain (col-
umn 3). These results show that Daxx modulates the tran-
scription activity of Skip.4. Discussion
Accumulating evidence indicates that Daxx plays an impor-
tant role in transcription regulation in addition to its role in
apoptosis. Daxx associates with several DNA-bound tran-
scription factors via its COOH-terminal region [17–20]. These
interactions are generally thought to mediate transcription
repression or activation in a cell- and promoter-speciﬁc man-
ner. Daxx also associates with transcription co-activators
and co-repressors, including histone deacetylase chromatin
remodeling complexes and the ATP-dependent chromatin-
remodeling complex [15,21,22,40]. Daxx appears to play a dy-
namic role in the assembly of transcription complexes; recent
studies suggest that it serves as a targeting unit of the ATRX:
Daxx ATP-dependent chromatin-remodeling complex and
facilitates the translocation of the complex to the PML-NBs,
thereby regulating its accessibility to the sequence-speciﬁc
transcription activator [21].
In the current work, we identiﬁed and characterized the
interaction between Daxx and a transcription co-factor Skip.
The lethality associated with the loss of Skip in a wide range
of organisms and the similar phenotypes between nematodes
deﬁcient in Skip and RNA polymerase II suggest that Skip
may be an essential component of transcription [33,41,42]. It
appears that Skip may to be a critical link between diverse
DNA-bound factors, co-activators and co-repressors, and the
basal transcription machinery. We show that Daxx and Skip
strongly associate with each other when they are overexpres-
sed. This interaction is mediated by the NH2-terminal region
of Daxx, which is separate from its region that binds to se-
quence-speciﬁc transcription factors, and by the evolutionarily
conserved SNW region of Skip. Daxx partially co-localizes
with Skip in vivo and modulates its activity. These results sug-
gest that Daxx and Skip collaborate in transcription regula-
tion. Because the Daxx:skip interaction was detected by the
yeast two-hybrid system and the mammalian cell overexpres-
sion approach, further study is needed to conﬁrm the interac-
tion between the endogenous proteins and their functional
relationship in vivo. To date, the biochemical function(s) of
Daxx remains unclear. However, in light of diverse proteins re-
ported to associate with Daxx, it is possible that Daxx may
have a more general role in regulating protein functions, such
as complex assembling, protein folding/unfolding, and cellular
targeting. The latter may be the case for the ATRX:Daxx com-
plex [21,22,43]. The current work suggests a similar role forDaxx in regard to Skip function, although Daxx does not seem
to target Skip to the PML-NBs.
We have also demonstrated that Skip is a phosphoprotein
and that serine 224 is a main phosphorylation site. The phos-
phorylation state of Skip does not appear to aﬀect its localiza-
tion and the Skip:Daxx interaction, nor does it aﬀect the
transcription activity of Skip in the reporter gene assay (data
not shown). However, given that phosphorylation is a general
mechanism that regulates transcription, it is conceivable that
phosphorylation may aﬀect other aspects of Skip function,
such as its interactions with other transcription factors and/
or cellular localization.
The relationship between the functions of Daxx in apopto-
sis and transcription is unclear at the present time. Recent
studies have shown that other proteins regulating transcrip-
tion and chromatin structure, such as p53, nuclear orphan
receptor TR3, and histone H1.2, also have a direct role in
apoptosis induction in the cytosol by triggering the release
of cytochrome c from the mitochondria [44–46]. Therefore,
proteins that have a dual role in regulating apoptosis in the
cytosol and chromatin dynamics in the nucleus exist more
widely than previously anticipated. Since Daxx appears to
function in apoptosis both in the nucleus and in the cytosol,
it may modulate the expression of genes critical for survival
and/or cell death. The translocation of Daxx from the nu-
cleus to the cytosol upon apoptosis induction may also alter
transcription in dying cells. Notably, Daxx is only found in
mice and humans while Skip is present in all eukaryotes. It
is possible that the Daxx:Skip interaction may present an
additional control on the transcription machinery in higher
organisms, linking transcription to other important cellular
processes such as apoptosis.Acknowledgements: We thank Dr. David Baltimore, in whose lab this
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